Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355 (miriplatin hydrate) - Safety and efficacy in combination with embolizing agents

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 2, 2010, Pages 271-275

  Ikeda, Kenji ^a   Okusaka, Takuji ^b   Ikeda, Masafumi ^c   Morimoto, Manabu ^d  

^a TORANOMON HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Hepatocellular carcinoma; Miriplatin; Transcatheter arterial chemoembolization

Indexed keywords

ANTINEOPLASTIC AGENT; MIRIPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LIVER CELL CARCINOMA; UNSPECIFIED SIDE EFFECT;

EID: 79960762042     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Maeda M. Uchida NA and Sasaki T: Liposoluble platinum (II) complexes with antitumor activity. Jpn J Cancer Res 77(6):523-525, 1986. (Pubitemid 16061614)
2. Kamada K, Nakanishi T, Kitamoto M, et al: Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 12(7):847-854, 2001. (Pubitemid 32642435)
3. Fujiyama S, Shibata J, Maeda S, et al: Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol. Br J Cancer 89(9):1614-1619, 2003. (Pubitemid 37464129)
4. Okusaka T, Okada S, Nakanishi T, et al: Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 22(2):169-176, 2004. (Pubitemid 38270472)
5. Ikeda K, Saitoh S, Kobayashi M, et al: Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma. J Gastroenterol 35(5):353-360, 2000. (Pubitemid 30386830)
6. Yamashita Y, Takahashi M, Fujimura M, et al: Clinical evaluation of hepatic artery embolization: comparision between Gelform and Lipiodol with anticancer agent. Radiat Med 5(3):61-67, 1987. (Pubitemid 18015892)
7. Okusaka T, Okada S, Ueno H, et al: Transcatheter arterial embolization with Zinostatin Stimalamer for hepatocellular carcinoma. Oncology 62(3):228-233, 2002. (Pubitemid 34639056)